GABA is the primary transmitter released by neurons of the suprachiasmatic nucleus (SCN), the circadian clock in the brain. Whereas GABA B receptor agonists exert a significant effect on circadian rhythms, the underlying mechanism by which GABA B receptors act in the SCN has remained a mystery. We found no GABA B receptor-mediated effect on slow potassium conductance, membrane potential, or input resistance in SCN neurons in vitro using whole-cell patch-clamp recording. In contrast, the GABA B receptor agonist baclofen (1-100 M) exerted a large and dose-dependent inhibition (up to 100%) of evoked IPSCs. Baclofen reduced the frequency of spontaneous IPSCs but showed little effect on the frequency or amplitude of miniature IPSCs in the presence of tetrodotoxin. The activation of GABA B receptors did not modulate postsynaptic GABA A receptor responses. The depression of GABA release by GABA B autoreceptors appeared to be mediated primarily through a modulation of presynaptic calcium channels. The baclofen inhibition of both calcium currents and evoked IPSCs was greatly reduced (up to 100%) by the P/Q-type calcium channel blocker agatoxin IVB, suggesting that P/Q-type calcium channels are the major targets involved in the modulation of GABA release. To a lesser degree, N-type calcium channels were also involved. The inhibition of GABA release by baclofen was abolished by a pretreatment with pertussis toxin (PTX), whereas the inhibition of whole-cell calcium currents by baclofen was only partially depressed by PTX, suggesting that G-protein mechanisms involved in GABA B receptor modulation at the soma and axon terminal may not be identical. We conclude that GABA B receptor activation exerts a strong presynaptic inhibition of GABA release in SCN neurons, primarily by modulating P/Qtype calcium channels at axon terminals.
The suprachiasmatic nucleus (SC N) of the hypothalamus acts as a circadian clock in the mammalian brain (Moore and Eichler, 1972; Stephan and Zucker, 1972 ; for review, see van den Pol and Dudek, 1993) . The inhibitory amino acid transmitter GABA is particularly important for SC N f unction. Most neurons here use GABA as their primary transmitter (van den Pol and Tsujimoto, 1985; Moore and Speh, 1993) . Half of all presynaptic boutons in the SC N contain GABA, and all neurons studied ultrastructurally were postsynaptic to GABAergic axons, partially arising from other SC N neurons (van den Pol, 1980; Decavel and van den Pol, 1990) .
GABA receptors can be divided into two broad groups, one that is coupled to C l Ϫ channels and is activated by GABA and muscimol and blocked in most cases by the GABA A antagonist bicuculline, and a second type that operates through G-proteins and is activated by GABA and baclofen and blocked by 2-hydroxysaclofen (Bormann, 1988) . GABA B receptors have been studied in many other brain regions, most extensively in the hippocampus. There GABA B receptors have both presynaptic and postsynaptic actions (Dutar and Nicoll, 1988; Lambert and Wilson, 1993; Pitler and Alger, 1994) . A substantial part of the mechanism of GABA B receptor action in hippocampus and most other brain regions is mediated by activation of K ϩ channels through pertussis toxin-sensitive G-proteins (for review, see Gage, 1992; Bowery, 1993; Misgeld et al., 1995) . Postsynaptic GABA B activation of K ϩ currents, often leading to hyperpolarization, has been found in many parts of the brain (for review, see Misgeld et al., 1995) . GABA B receptors can also modulate Ca 2ϩ channels (Mintz and Bean, 1993; Pfrieger et al., 1994; Diversé-Pierluissi et al., 1995; Dittman and Regehr, 1996; Lambert and Wilson, 1996; Rhim et al., 1996, Obrietan and van den Pol, 1998) and thereby inhibit neurotransmission (Scholz and Miller, 1991; Doze et al., 1995; Huston et al., 1995; Isaacson and Hille, 1997) .
Autoradiographic studies have shown GABA B receptor binding in the SCN (Francois-Bellan et al., 1989) . In parallel, a number of studies have shown that GABA or GABA B receptor agonists applied to the SCN phase shift circadian rhythms (Ralph and Menaker, 1989; Gannon et al. 1995; Gillespie et al., 1997) . Despite the large body of evidence for GABA B actions relating to circadian rhythms, all postsynaptic GABA responses could be completely blocked by the antagonist bicuculline, leading to the conclusion that GABA A receptors probably account for all of the postsynaptic actions of GABA in the SCN (Kim and Dudek, 1992) . To address the mystery of what mechanism GABA B actions in the SCN might be operating through, we examined several questions in the present study. If no postsynaptic GABA Bmediated slow IPSPs can be detected, do presynaptic GABA B receptors act on axon terminals? What is the ion channel target of GABA B actions? C an G-protein blockers alter GABA B receptor actions?
To differentiate presynaptic from postsynaptic actions clearly, we used cultures of SC N neurons consisting of either single self-innervating neurons or multicellular synaptically coupled neurons. Previous work has shown that SC N neurons in vitro demonstrate many of the same actions that they do in vivo, including GABA release and response to GABA van den Pol, 1996, 1997) . Furthermore, neurons in isolated SCN slices in vitro show circadian rhythms of activity (Inouye and Kawamura, 1979) , and even single SC N neurons in culture show circadian rhythms of electrical activity (Welsh et al., 1995) . Because of the robust presence of GABA, we tested the hypothesis that GABA would have a potent presynaptic action on GABAergic axons of SC N neurons.
MATERIALS AND METHODS
Cell culture. High-density multicell culture and low-density microculture of SC N neurons were used and have been described previously in detail van den Pol, 1996, 1997) . Briefly, the SC Ns were dissected from brain slices containing optic chiasm removed from postnatal pups (postnatal days 1 and 2) of Sprague Dawley rats. The tiny tissue blocks were incubated for 30 min in a enzyme solution containing 10 U/ml papain, 0.5 mM EDTA, 1.5 mM CaCl 2 , and 0.2 mg /ml L-cysteine. After washing the tissue twice with culture medium, cells were dissociated by mechanical trituration and plated on 35 mm Petri dishes (Corning, Corning, N Y) . For multicell cultures, a high density of cells (Ͼ20,000 cells/cm 2 ) was plated in the central area of culture dishes precoated with poly-D-lysine (0.3 mg /ml). For microcultures, a low density of glial cells (ϳ2000 cells/cm 2 ) was first plated on 35 mm Petri dishes. After 2-3 d of culture, 5 M cytosine arabinoside (AR A-C) was added into culture medium to arrest the proliferation of glial cells. One to 2 d later, a low density of neurons (3000 cells/cm 2 ) was plated in dishes containing microislands of glial cells (Furshpan et al., 1986; Bekkers and Stevens, 1991; Johnson, 1994; van den Pol, 1996, 1997) . After 1-2 weeks of culture, single neurons grown on microislands of glial cells form synapses with themselves, and autaptic I PSC s can be reliably evoked by depolarizing pulses van den Pol, 1996, 1997) . The culture medium contained minimal essential medium (Life Technologies, Gaithersburg, MD) supplemented with 10% fetal calf serum (Hyclone, L ogan, UT) and serum extender (Collaborative Research, Bedford, M A), 100 U/ml penicillin and streptomycin, and 6 g / l glucose. T wo micromolar AR A-C was added 2 d after plating neurons. The cultures were maintained in an incubator at 37°C and 5% C O 2, and fed twice weekly.
Electrophysiolog y. E xperimental procedures for whole-cell voltageclamp and current-clamp recordings have been detailed previously van den Pol, 1996, 1997) . In brief, a List EPC -7 amplifier interfaced with an Apple Macintosh computer was used to acquire data with AxoData software. Axograph and Igor Pro software were used to analyze data. Data were sampled at 2-5 kHz and filtered at 1 kHz by an eight pole Bessel filter (Frequency Devices). Micropipettes were pulled from thinwall borosilicate glass (World Precision Instruments) using a Narishige vertical puller, with a tip diameter of ϳ2 m. The pipette resistance was ϳ3 M⍀ after filling with the pipette solution. The series resistance was monitored continuously by application of a negative voltage pulse (Ϫ10 mV, 30 msec), and compensated by 40 -70% with the amplifier. A brief depolarizing pulse (70 mV, 2 msec) was used to evoke presynaptic GABA release in single autaptic neurons, with a holding potential usually at Ϫ60 mV. Postsynaptic GABA receptor responses were induced by a brief pressure ejection of GABA (50 M, 2-4 psi, 10 msec) through a micropipette (2 m tip diameter) under computer control with the use of a Picospritzer (General Valve, Fairfield, NJ). The recording chamber was perf used continuously (2 ml /min) with a bath solution containing (in mM): 150 NaC l, 2.5 KC l, 2 C aC l 2 , 10 H EPES, and 10 glucose, pH 7.3. The pipette solution contained (in mM): 145 KC l, 0.5 K 4 -EGTA, 10 H EPES, 4 Mg-ATP, and 0.5 Na 2 -GTP, pH 7.3. For recording of whole-cell C a 2ϩ currents, the bath solution contained (in mM): 110 NaC l, 40 TEA-C l, 2.5 KC l, 5 BaC l 2 , 10 H EPES, 10 glucose, and 1 M tetrodotoxin (TTX), pH 7.3; the pipette solution contained (in mM): 145 C sC l, 2 C s 4 -EGTA, 10 H EPES, 4 Mg-ATP, and 0.5 Na 2 -GTP, pH 7.3. Drugs were applied through a series of glass flow pipes (400 m inner diameter) fed by gravity. E xperiments were done at room temperature (22°C).
Baclofen, GABA, (Ϫ)-bicuculline methiodide, 6-cyano-7-nitroquinoxaline-2,3-dione (C NQX), TTX, -conotoxin GV IA, Mg-ATP, and Na 2 -GTP were purchased from Sigma (St. L ouis, MO); 2-hydroxysaclofen and nimodipine were from Research Biochemical International (RBI, Natick, M A); agatoxin IV B (also known as agatoxin TK , similar to agatoxin IVA) was from Peptide International; pertussis toxin (P TX) was from Sigma and RBI. Nimodipine was dissolved in methanol to 10 mM. The final concentration was 4 M; the 0.04% methanol vehicle had no effect on C a 2ϩ currents or transmitter release. Toxins were dissolved in distilled water, aliquoted, and stored at Ϫ80°C.
RESULTS

GABA B receptor activation inhibits evoked IPSCs
The SCN contains primarily GABAergic neurons. GABA A receptors mediating GABA neurotransmission in the SCN have been well documented (for review, see van den Pol et al., 1996) . However, the function of GABA B receptors remains poorly understood. We examined the possible function of GABA B receptors in SCN cultures by applying the specific GABA B receptor agonist baclofen. A profound inhibition of GABA neurotransmission by baclofen was observed in a dose-dependent manner. In some neurons a complete (100%) block was found with high concentrations (100 M) of baclofen. Figure 1 shows the action of baclofen on evoked autaptic IPSCs. Figure 1 , A and B, shows a typical neuron in which baclofen at concentrations of 1-100 M potently inhibited the evoked I PSC s in a dose-dependent manner. Figure 1C is a bar graph showing the group data of baclofen reduction of evoked I PSC s at various concentrations. The IC 50 of baclofen was 5-10 M.
To ensure that the baclofen inhibition on I PSC s was induced specifically by activating GABA B receptors, a GABA B receptor antagonist, 2-hydroxysaclofen, was used to antagonize the baclofen effect. Figure 2 , A and B, demonstrates that the evoked IPSC was totally blocked by the GABA A receptor antagonist bicuculline (30 M). The GABA B receptor agonist baclofen (10 M) inhibited the amplitude of the I PSC by ϳ50%. Bath application of the GABA B receptor antagonist 2-hydroxysaclofen (500 M) increased the amplitude of the I PSC in this neuron. In the presence of 2-hydroxysaclofen, the baclofen inhibition of the IPSC amplitude was greatly reduced (from 50 to 12%). After washing off 2-hydroxysaclofen, application of baclofen again produced a large inhibition of I PSC s (50%). Similar experiments were repeated in six neurons. Baclofen inhibition before and during 2-hydroxysaclofen was 46.3 Ϯ 5.8 and 8.0 Ϯ 2.3% (n ϭ 7), respectively, a difference that is statistically significant ( p Ͻ 0.01, t test), suggesting that the inhibition of baclofen on evoked IPSCs was attributed to the specific activation of GABA B receptors. The fact that application of 2-hydroxysaclofen increased the mean basal amplitude of synaptically evoked I PSC s (9.3 Ϯ 0.7%) suggests that GABA B receptors were activated by synaptically released GABA transmitter, and that the GABA B receptor may participate in a tonic depression of GABA release.
Baclofen inhibits GABA release through a presynaptic mechanism
The potent inhibition of baclofen on neurotransmission could possibly be mediated at either presynaptic or postsynaptic sites. In brain slices, GABA B receptor-mediated slow I PSPs were not detected in the SC N (K im and Dudek, 1992). To examine whether there is any GABA B receptor-mediated slow IPSPs or IPSC s in our SC N cultures, antagonists for both GABA A and GABA B receptors were used to differentiate fast and slow components. Figure 3 demonstrates the absence of postsynaptic GABA B receptor-mediated slow responses in cultured SCN neurons, in agreement with brain slice experiments (Kim and Dudek, 1992) . Figure 3A illustrates that the GABA A receptor antagonist bicuculline (30 M) totally blocked the evoked IPSC. Additional application of GABA B receptor antagonist 2-hydroxysaclofen (500 M) together with bicuculline had no further effect (n ϭ 4). The holding potential was maintained at Ϫ45 mV to facilitate the detection of GABA B receptor-mediated slow responses by increasing the driving force. The effect of GABA B receptor activation on membrane potential and membrane conductance was further examined. Figure 3 , B and C, demonstrates that application of baclofen (10 M) under both voltage-clamp and currentclamp conditions potently inhibited spontaneous IPSCs and IPSPs but had no effect on the membrane current (n ϭ 12) or membrane potential (n ϭ 4). The downward current injectioninduced hyperpolarizing potentials in Figure 3C remained constant before and during baclofen application, indicating no membrane conductance change induced by baclofen (n ϭ 4). Together, these results suggest that baclofen inhibits GABA neurotransmission not through a postsynaptic mechanism but solely through activation of presynaptic GABA B autoreceptors.
For a direct demonstration of a presynaptic action of GABA B receptors, we compared the effect of baclofen on presynaptically evoked I PSC s with postsynaptic flow pipe GABA applicationinduced responses in single self-innervating neurons. The box in Figure 4 A illustrates the experimental arrangement. Figure 4 , A-C, demonstrates that baclofen (5 M) strongly inhibited the presynaptically evoked I PSC but had little effect on the postsynaptic GABA response in the same neuron. Figure 4 D is a line graph showing the differential effect of baclofen on presynaptic and postsynaptic responses of a single neuron. Grouped data from six neurons are summarized in Figure 4 E, demonstrating a significant reduction of presynaptically evoked I PSC s ( p Ͻ 0.001) by baclofen but no effect on postsynaptic GABA applicationinduced responses ( p Ͼ 0.5), suggesting a specific action of baclofen on presynaptic GABA release instead of a modulation of postsynaptic GABA receptors.
To address f urther the mechanism of baclofen actions on GABA neurotransmission, spontaneous I PSC s in the absence and presence of TTX (1 M) were examined. The glutamate receptor antagonist C NQX (10 M) was routinely added to the bath solution, and this eliminated glutamatergic EPSCs. Figure  5A1 illustrates that in the normal bath solution without TTX there were many large I PSC s attributed to the spontaneous firing of action potentials. Baclofen (10 M) eliminated almost all of the large IPSCs, whereas small IPSCs persisted. Figure 5A2 is an amplitude distribution histogram (n ϭ 4) demonstrating a significant inhibition of large-amplitude IPSCs by baclofen (white bar). The median amplitude of IPSCs before baclofen was 59.2 pA (range, 5.2-4920 pA) and after baclofen was 35.6 pA (range, 5.4 -3343 pA). There is a significant difference between the two amplitude distribution histograms before and after baclofen application ( p Ͻ 0.001, Kolmogorov-Smirnov test). Figure 5B1 illustrates that in the presence of TTX (1 M), baclofen (10 M) had no remarkable effect on miniature IPSCs (mIPSCs). This is supported by the amplitude distribution histogram (n ϭ 5) shown in Figure 5B2 . Baclofen did not significantly alter the amplitude distribution histogram of mIPSCs ( p Ͼ 0.2, KolmogorovSmirnov test). The median mIPSC amplitude before baclofen was 33.0 pA (range, 5.1-130.9 pA) and after baclofen was 32.8 pA (range, 5.2-122.8 pA). The absence of an effect of baclofen on the amplitude of mIPSCs provides further evidence that baclofen does not modulate postsynaptic GABA A receptors. The substantial inhibition of baclofen on action potential evoked-large IPSCs but little effect on TTX resistant mIPSCs suggests that the baclofen inhibition may be related to Ca 2ϩ influx, possibly through modulation of voltage-dependent Ca 2ϩ channels.
P/Q-type calcium channels are the major target of GABA B receptor modulation
Whole-cell Ca 2ϩ currents, using Ba 2ϩ as the carrier, were evoked by a depolarizing pulse of 40 msec, 90 mV at a holding potential of Ϫ90 mV. Figure 6 A illustrates that the whole-cell Ca 2ϩ currents were almost completely blocked by 100 M Cd (n ϭ 3). In the same neuron, baclofen (1 M) also reversibly inhibited the whole-cell Ca 2ϩ current. Figure 6 B shows a dose-dependent inhibition of baclofen on whole-cell Ca 2ϩ currents. The IC 50 of baclofen was between 1 and 10 M, the same range of the IC 50 of baclofen on evoked IPSCs (see Fig. 1 ).
Multiple types of Ca 2ϩ channels, including L-, N-, P-, and Q-type, have been characterized in central and peripheral neurons (Tsien et al., 1988; Bean, 1989; Llinas et al., 1992) . To test the hypothesis that baclofen inhibits evoked IPSCs in SCN neu- rons by modulating specific subtypes of C a 2ϩ channels, selective Ca 2ϩ channel blockers were used. Figure 7A illustrates that after application of the L -type C a 2ϩ channel blocker nimodipine (4 M) and N-type C a 2ϩ channel blocker conotoxin GVIA (2 M), additional application of baclofen (10 M) inhibited the remaining non-L / N C a 2ϩ currents. Similar results were found in four of six neurons. In another two neurons, baclofen inhibition disappeared after blocking N-type C a 2ϩ currents (see Fig. 9 ). Figure  7B shows a parallel experiment testing the effect of baclofen on evoked I PSC s in the presence of L -or N-type C a 2ϩ channel blockers. Blocking L -type channels by nimodipine (4 M) had no effect on evoked IPSCs (n ϭ 3), indicating no participation of L-type channels in synaptic GABA release in SCN neurons. The N-type channel blocker conotoxin GVIA (2 M) significantly reduced the evoked IPSC, suggesting that N-type channels mediate GABA release in SCN axons. After the reduction of IPSC amplitude by conotoxin GVIA (2 M), application of baclofen (10 M) further inhibited the remaining IPSC, suggesting a target other than N-type channels being involved in baclofen inhibition. Figure 8 A demonstrates that the remaining non-L/N Ca 2ϩ current modulated by baclofen in Figure 7A may be mediated by P/Q-type Ca 2ϩ channels. In this representative neuron of five tested, the baclofen inhibition of C a 2ϩ currents disappeared after treatment with agatoxin IV B (500 nM, also known as agatoxin TK), a specific blocker of P/Q-type channels (Teramoto et al., 1993) , suggesting that the C a 2ϩ current component modulated by baclofen was a P/Q-type current. Figure 8 B shows a parallel experiment of baclofen combined with agatoxin IV B on evoked IPSC s (n ϭ 5). Repeated application of baclofen (10 M) reversibly inhibited I PSC s. After application of agatoxin IVB (500 nM), the application of baclofen induced no inhibition, suggesting that the agatoxin IV B sensitive P/Q-type C a 2ϩ channels are the target of baclofen modulation.
Although P/Q-type C a 2ϩ channels appear to be the major targets of baclofen modulation in many SC N neurons, N-type Ca 2ϩ channels may also be modulated. Figure 9A shows one example of two neurons in which baclofen (10 M) inhibition of Ca 2ϩ currents did not occur after blocking N-type currents by conotoxin GV IA (2 M), suggesting a direct modulation of N-type channels by baclofen. In a parallel experiment of evoked IPSC s combining baclofen with conotoxin GV IA as shown in Figure 9B , baclofen (10 M) in the control condition greatly reduced the I PSC amplitude from 2.9 to 0.7 nA, whereas after application of conotoxin GV IA (2 M), baclofen (10 M) only reduced the I PSC from 1.5 to 0.7 nA, suggesting that N-type channels are part of the target of baclofen modulation. Figure 10 summarizes the change of baclofen inhibition of both Ca 2ϩ currents and evoked IPSCs before and after application of conotoxin GVIA and agatoxin IVB. The average (n ϭ 6) baclofen inhibition of Ca 2ϩ currents before conotoxin GVIA was 46.0 Ϯ 6.2% and after conotoxin GVIA was 51.4 Ϯ 10.4%, showing no significant difference (paired t test, p Ͼ 0.3). Whereas no significant conotoxin GVIA inhibition of baclofen actions was found in the group mean, two of the six neurons tested did show a conotoxin GVIA-mediated block of the baclofen inhibition (Fig. 9A) . In contrast to the N-type Ca 2ϩ channel blocker, the P/Q channel blocker showed a substantial block of the baclofen effect. The baclofen inhibition of Ca 2ϩ currents before agatoxin IVB was 47.2 Ϯ 4.1% and after agatoxin IVB was 11.4 Ϯ 2.5%, showing a significant reduction (n ϭ 4; paired t test, p Ͻ 0.001). In parallel with the action on Ca 2ϩ currents, the mean baclofen inhibition of evoked IPSCs before conotoxin GVIA was 49.1 Ϯ 6.1% and after conotoxin GVIA was 42.3 Ϯ 6.6%, having no statistical significance (n ϭ 5, paired t test, p Ͼ 0.2). However, the baclofen inhibition of IPSCs before agatoxin IVB was 52.7 Ϯ 7.9% and after agatoxin IVB was 19.6 Ϯ 5.8%, indicating that the P/Q channel blocker mediated a significant reduction in the baclofen inhibition of IPSCs (n ϭ 7; paired t test, p Ͻ 0.01).
Together, these results demonstrate that baclofen strongly modulates P/Q-type and in some cells N-type Ca 2ϩ channels. This inhibitory modulation may underlie the mechanism of baclofen inhibition on GABA neurotransmission in the SCN. 
Involvement of PTX-sensitive and -insensitive G-proteins
GABA B receptors may be coupled to G-proteins in many central neurons (Gage, 1992; Misgeld et al., 1995) . To determine whether GABA B receptors in SC N neurons are linked to P TX-sensitive G-proteins, SC N cultures were treated with P TX (300 ng/ml) for 48 hr before baclofen was tested. Surprisingly, we found a differential effect of baclofen on evoked I PSC s and C a 2ϩ currents after treatment of P TX. Figure 11 , A-C, illustrates an example in which, in the same autaptic neuron, baclofen (10 M) had no effect on evoked I PSC s but produced a remarkable inhibition (45%) of C a 2ϩ currents. This phenomenon was confirmed by using P TX from two different sources (Sigma and RBI), and repeated in different cultures. Figure 11 D summarizes data from 14 neurons after P TX pretreatment, examining the differential baclofen effect on I PSC s and C a 2ϩ currents. The inhibition of baclofen on evoked I PSC s was clearly blocked by P TX pretreatment, suggesting that baclofen modulation of synaptic GABA release, possibly by modulation of presynaptic N-and P/Q-type Ca 2ϩ channels, is dependent on P TX-sensitive G-proteins. The baclofen inhibition of whole-cell C a 2ϩ currents was reduced (from 50 to 25%) but not f ully blocked after P TX pretreatment, indicating that part of the baclofen modulation of C a 2ϩ currents may be mediated by P TX-insensitive G-proteins.
DISCUSSION
Although substantial effects of GABA B receptors on phase shifts of circadian rhythms, general neuronal activity levels, and c-Fos gene expression are found in the SCN (Ralph and Menaker, 1989; Colwell et al., 1993; Gannon et al., 1995; Gillespie et al., 1997) , specific actions of GABA B receptors were not detected in electrophysiological studies (Kim and Dudek, 1992) . Our data suggest that this apparent mystery is not a real discrepancy but instead is caused by a substantial block of transmitter release from presynaptic GABA B autoreceptors, rather than a postsynaptic GABA B receptor-mediated slow hyperpolarizing response found in many other brain regions. The mechanism underlying the presynaptic modulation of GABA neurotransmission in SCN neurons appears to be mediated by a strong inhibition of Ca 2ϩ channels, specifically the P/Q-and N-type channels.
Presynaptic action of GABA B receptors
In most other regions of the brain, GABA B receptors at postsynaptic sites inhibit activity by increasing K ϩ conductance and thus hyperpolarizing the membrane potential, resulting in slow IPSPs (Newberry and Nicoll, 1984; Gahwiler and Brown, 1985; Stevens et al., 1985; Crunelli et al., 1988; Lacey et al., 1988; Osmanovic and Shefner, 1988) . In previous work examining the actions of GABA B receptors in SCN slices, no slow IPSPs were found (Kim and Dudek, 1992) . Similarly, we detected no evidence of GABA B -mediated membrane potential changes in SCN neurons. However, in striking contrast to the lack of GABA B inhibition of GABA A responses at the soma, we found substantial GABA Bmediated inhibition in presynaptic SC N axons that released GABA. Phase shifts of circadian rhythms regulated by the SCN can be generated by GABA B agonists (Ralph and Menaker, 1989; Gannon et al., 1995; Gillespie et al., 1997) . Our data suggest that the primary action of GABA B receptors in SC N neurons may be to modulate GABA release from axon terminals; this inhibiton of GABA release may be one possible cellular substrate that plays a role in phase shifting.
Inhibition of calcium channels
GABA B receptors reduced C a 2ϩ currents in SC N neurons. The channel that showed the greatest response to baclofen was the voltage-activated P/Q-type C a 2ϩ channel. This channel appeared to account for a substantial C a 2ϩ current. This is the first demonstration of the relative importance of the P/Q channel in SCN neurons. N-type channels were also modulated by GABA B receptor activation. These channels (P/Q and N) may mediate the primary C a 2ϩ influx in presynaptic axons required to trigger transmitter release. Blocking their actions with specific blockers substantially reduced the actions of GABA B receptors, suggesting that C a 2ϩ channels are the major effector of GABA B receptor modulation.
GABA B modulation of SC N neurons can be compared with hippocampal neurons, in which GABA B receptors have been studied more extensively. The SCN primarily contains GABAergic neurons, whereas the hippocampus contains both glutamatergic and GABAergic neurons. In the hippocampus, GABA B receptors modulate neurotransmission both presynaptically and postsynaptically and modulate both K ϩ and Ca 2ϩ channels (Dutar and Nicoll, 1988; Lambert and Wilson, 1993; Pfrieger et al., 1994; Doze et al., 1995) . In contrast in the SCN, GABA B receptors modulate neurotransmission in a specific presynaptic way and only modulate Ca 2ϩ channels, with little detectable effect on K ϩ channels (Kim and Dudek, 1992 ; this study). In hippocampal glutamatergic neurons, the miniature EPSCs in the presence of TTX were significantly affected by GABA B receptors (Scanziani et al., 1992; Dittman and Regehr, 1996) . However, in both hippocampal and SCN GABAergic neurons, the miniature IPSCs were not modulated by GABA B receptors (Doze et al., 1995; this study) . Furthermore, in both hippocampal and SCN inhibitory neurons, GABA B receptors modulate both P/Q-type and N-type Ca 2ϩ channels, with a larger effect on P/Q-type Ca 2ϩ channels. Whether these shared common properties of inhibitory hippocampal and SCN neurons can be extended to other GABAergic central neurons needs further work.
Modulation of calcium channels underlying the inhibition of GABA release
The present study demonstrates that the activation of GABA B receptors inhibited both whole-cell Ca 2ϩ currents and presynaptic GABA release in SCN neurons. GABA B receptors can influence Ca 2ϩ currents at the cell body and may modulate GABA release from the presynaptic axon in a similar manner. This is supported by several lines of evidence. First, baclofen inhibited both evoked IPSCs and Ca 2ϩ currents in a dose-dependent manner. Second, baclofen strongly inhibited action potentialdependent IPSCs in the absence of TTX but had little effect on miniature IPSCs in the presence of TTX, suggesting that the release apparatus down-stream of Ca 2ϩ influx is not modulated (Dittman and Regehr, 1996) . More direct evidence comes from the parallel experiments using a combination of selective Ca 2ϩ channel blockers together with baclofen. Baclofen inhibition of IPSCs was largely eliminated in the presence of Ca 2ϩ channel blockers -conotoxin GVIA and agatoxin IVB, indicating that Ca 2ϩ channels are probable mediators of GABA B receptor modulation in presynaptic nerve terminals.
Because it is difficult to measure Ca 2ϩ currents directly at the small SCN axon terminals, we measured Ca 2ϩ currents at the cell body. Although both the cell body and axon terminals may express similar Ca 2ϩ channels, Ca 2ϩ influx at the terminal may not be the same as at the cell body. The channel density and relative proportion of each specific type (L-, N-, P/Q-, and R-type) may be different in the soma and axon terminals of the same cell.
GABA B -related G-proteins
The actions of GABA B receptors on the presynaptic GABA release were substantially blocked by PTX. In contrast, the actions of GABA B receptors on the somatic Ca 2ϩ channels were only partially blocked by PTX. This suggests that although somatic Ca 2ϩ channels in the SCN can be modulated by a PTXsensitive GABA B action, there may be additional mechanisms whereby PTX-insensitive G-proteins also play a modulatory role in Ca 2ϩ channels. Another possibility is that a different response to PTX exists in somata and presynaptic axons. A simplified scheme illustrating a differential modulation of GABA B receptors on presynaptic and postsynaptic Ca 2ϩ channels is shown in Figure 12, in which presynaptic P/Q-type and N-type channels are modulated by P TX-sensitive G i and G 0 proteins, but postsynaptic Ca 2ϩ channels (including P/Q-, N-, and L -type) are modulated by both P TX-sensitive and -insensitive G-proteins.
Our data indicate that the GABA B autoreceptors modulate presynaptic GABA release by activating P TX-sensitive G-proteins. This is in contrast to one group of reports that found little effect of P TX on GABA B actions in presynaptic axons in hippocampal preparations (Dutar and Nicoll, 1988; Thompson and Gahwiler, 1992 ) but similar to another group that found that P TX blocked presynaptic effects of GABA B receptors on axon terminals (Scholz and Miller, 1991; Pfrieger et al., 1994; Pitler and Alger, 1994) . These differences could be caused by multiple mechanisms of GABA B actions in the hippocampus or to different activational states of the GABA B receptor-second messenger system in different preparations. One advantage of the single neuron culture approach we used is that P TX has f ull access to all parts of the neuron plasma membrane. The same may not be true when P TX or related agents are injected into the brain or applied to brain slices in which diff usion may be impeded by multiple layers of astrocytes that surround axon terminals.
Functional implications
The modulation of intracellular C a 2ϩ may be generally relevant to phase shifting and clock mechanisms. For instance, in bulla, phase shifts of the circadian clock in the ocular circadian pacemaker are blocked by C a 2ϩ channel antagonists (Khalsa and Block, 1988) . Similarly, C a 2ϩ can modulate the circadian variation of melatonin secretion in chick pineal cells (Nikaido and Takahashi, 1996) . In previous work on the rat SCN in vitro, intracellular C a 2ϩ was found to play a crucial role in the maintenance of circadian rhythms of 2-deoxyglucose utilization (Shibata et al., 1987) . The participation of GABA B receptors in modulating C a 2ϩ influx may allow GABA to modulate cytoplasmic C a 2ϩ levels, thereby potentially influence clock timing. Previous studies have shown that GABA A and GABA B receptors may both play important roles in the phase-shifting actions of light on circadian rhythms (Ralph and Menaker, 1989; Gannon et al., 1995; Gillespie et al., 1997) . The present study is the first to demonstrate a widespread and profound action of GABA B receptors on SCN neurons themselves, and that GABA released by axons of SCN neurons can act autosynaptically, depressing further GABA release from the same axon terminal. Golgi impregnation studies of SCN axons show substantial axon collaterals within the nuclei (van den Pol, 1980) . Although many SCN synapses are surrounded by astrocytes that may inhibit free diffusion to other axon terminals (van den Pol et al., 1992) , in some cases GABA can diffuse from an active axon to another nearby (Isaacson et al., 1993) . Although the immediate action of GABA is inhibitory, the GABA B receptor-mediated inhibition of GABA release could have a net positive effect on local synaptic circuits by reducing inhibition.
A primary action of GABA B receptors in SCN neurons appears to be the modulation of GABA release from axons, and this inhibition of GABA release may be one cellular substrate influencing circadian phase shifts. Figure 12 . Simplified diagram illustrating G-protein-mediated presynaptic and postsynaptic GABA B receptor (GABA B R) modulation of multiple-type calcium channels.
